secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2026-08-04T10:50:18+00:00
Accession:  0001193125-26-331488
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pediatrix Q2 2026: Adjusted EPS $0.63, revenue $488M, reaffirms FY EBITDA $280-300M
--------------------------------------------------------------------------------

- Net revenue $487.8M, up 4.0% YoY; net income $39.8M ($0.49 diluted EPS) vs $39.3M ($0.46) YoY.
- Adjusted EPS $0.63 vs $0.53 YoY; Adjusted EBITDA $76.4M vs $73.2M YoY.
- Same-unit revenue up 1.9% (reimbursement +4.0%, volume -2.1%); NICU days down 3.2%.
- Reaffirmed FY 2026 Adjusted EBITDA guidance of $280M-$300M.
- Used $42.7M for share repurchases in Q2; total debt $584M, cash $288.9M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000119312526331488/0001193125-26-331488-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000119312526331488/md-20260804.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-331488

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer